Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study-Reference-Cited by-同舟云学术

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

Published:2017-12 Issue:1 Volume:17 Page:
ISSN:1471-2466
Container-title:BMC Pulmonary Medicine
language:en
Short-container-title:BMC Pulm Med

Author:

McLaughlin Vallerie V.,Jansa Pavel,Nielsen-Kudsk Jens E.,Halank Michael,Simonneau Gérald,Grünig Ekkehard,Ulrich Silvia,Rosenkranz Stephan,Gómez Sánchez Miguel A.,Pulido Tomás,Pepke-Zaba Joanna,Barberá Joan Albert,Hoeper Marius M.,Vachiéry Jean-Luc,Lang Irene,Carvalho Francine,Meier Christian,Mueller Katharina,Nikkho Sylvia,D’Armini Andrea M.

Funder

Bayer AG

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12890-017-0563-7.pdf

Reference19 articles.

1. Lang IM, Klepetko W. Chronic thromboembolic pulmonary hypertension: an updated review. Curr Opin Cardiol. 2008;23:555–9.

2. Peacock A, Simonneau G, Rubin L. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3:608–14.

3. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S43–54.